Welsh, Carson, Anderson & Stowe, a New York-based leveraged buyout firm, announced Monday that it will pay $1.7 billion to acquire and take private Houston-based U.S. Oncology, a publicly-owned manager of cancer treatment centers across the country. U.S. Oncology treats approximately 15 percent of newly diagnosed cancer patients each year through a network of 875 physicians in 32 states.
Houston's Clear Thinkers
Longtime Houston attorney Tom Kirkendall's observations on developments in law, business, medicine, culture, sports, and other matters of general interest to the Houston business, professional, and academic communities.
